|Post IPO Valuation|
|Description||global pharmaceutical company|
|MAP Pharmaceuticals, 1/2013||$958M|
|Vicept Therapeutics, 7/2011||$275M|
|Serica Technologies, 2/2010|
Allergan, Inc. is a multi-specialty health care company focused on discovering, developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to live life to its greatest potential to see more clearly, move more freely, express themselves more fully.